Report Summary
The global Specialty Pharmaceutical market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Specialty Pharmaceutical market based on company, product type, end user and key regions.
This report studies the global market size of Specialty Pharmaceutical in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Specialty Pharmaceutical in these regions.
This research report categorizes the global Specialty Pharmaceutical market by top players/brands, region, type and end user. This report also studies the global Specialty Pharmaceutical market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Roche
Amgen
AbbVie
Novo Nordisk
Johnson & Johnson
Sanofi-Aventis
Merck
Eli Lilly
Novartis
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Innovent
Market size by Product
Antibody
Hormone
Growth Factors
Other
Market size by End User
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Specialty Pharmaceutical market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Specialty Pharmaceutical market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Specialty Pharmaceutical companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Specialty Pharmaceutical submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Specialty Pharmaceutical are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Specialty Pharmaceutical market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Specialty Pharmaceutical Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Specialty Pharmaceutical Market Size Growth Rate by Product
1.4.2 Antibody
1.4.3 Hormone
1.4.4 Growth Factors
1.4.5 Other
1.5 Market by End User
1.5.1 Global Specialty Pharmaceutical Market Size Growth Rate by End User
1.5.2 Tumor
1.5.3 Diabetes
1.5.4 Cardiovascular
1.5.5 Hemophilia
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Specialty Pharmaceutical Market Size
2.1.1 Global Specialty Pharmaceutical Revenue 2017-2027
2.1.2 Global Specialty Pharmaceutical Sales 2017-2027
2.2 Specialty Pharmaceutical Growth Rate by Regions
2.2.1 Global Specialty Pharmaceutical Sales by Regions
2.2.2 Global Specialty Pharmaceutical Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Specialty Pharmaceutical Sales by Manufacturers
3.1.1 Specialty Pharmaceutical Sales by Manufacturers
3.1.2 Specialty Pharmaceutical Sales Market Share by Manufacturers
3.1.3 Global Specialty Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.2 Specialty Pharmaceutical Revenue by Manufacturers
3.2.1 Specialty Pharmaceutical Revenue by Manufacturers (2017-2020)
3.2.2 Specialty Pharmaceutical Revenue Share by Manufacturers (2017-2020)
3.3 Specialty Pharmaceutical Price by Manufacturers
3.4 Specialty Pharmaceutical Manufacturing Base Distribution, Product Types
3.4.1 Specialty Pharmaceutical Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Specialty Pharmaceutical Product Type
3.4.3 Date of International Manufacturers Enter into Specialty Pharmaceutical Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Specialty Pharmaceutical Sales by Product
4.2 Global Specialty Pharmaceutical Revenue by Product
4.3 Specialty Pharmaceutical Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Specialty Pharmaceutical Breakdown Data by End User
6 North America
6.1 North America Specialty Pharmaceutical by Countries
6.1.1 North America Specialty Pharmaceutical Sales by Countries
6.1.2 North America Specialty Pharmaceutical Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Specialty Pharmaceutical by Product
6.3 North America Specialty Pharmaceutical by End User
7 Europe
7.1 Europe Specialty Pharmaceutical by Countries
7.1.1 Europe Specialty Pharmaceutical Sales by Countries
7.1.2 Europe Specialty Pharmaceutical Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Specialty Pharmaceutical by Product
7.3 Europe Specialty Pharmaceutical by End User
8 Asia Pacific
8.1 Asia Pacific Specialty Pharmaceutical by Countries
8.1.1 Asia Pacific Specialty Pharmaceutical Sales by Countries
8.1.2 Asia Pacific Specialty Pharmaceutical Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Specialty Pharmaceutical by Product
8.3 Asia Pacific Specialty Pharmaceutical by End User
9 Central & South America
9.1 Central & South America Specialty Pharmaceutical by Countries
9.1.1 Central & South America Specialty Pharmaceutical Sales by Countries
9.1.2 Central & South America Specialty Pharmaceutical Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Specialty Pharmaceutical by Product
9.3 Central & South America Specialty Pharmaceutical by End User
10 Middle East and Africa
10.1 Middle East and Africa Specialty Pharmaceutical by Countries
10.1.1 Middle East and Africa Specialty Pharmaceutical Sales by Countries
10.1.2 Middle East and Africa Specialty Pharmaceutical Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Specialty Pharmaceutical by Product
10.3 Middle East and Africa Specialty Pharmaceutical by End User
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Pfizer Specialty Pharmaceutical Products Offered
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Company Business Overview
11.2.3 Roche Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Roche Specialty Pharmaceutical Products Offered
11.2.5 Roche Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Company Business Overview
11.3.3 Amgen Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Amgen Specialty Pharmaceutical Products Offered
11.3.5 Amgen Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 Company Business Overview
11.4.3 AbbVie Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2020)
11.4.4 AbbVie Specialty Pharmaceutical Products Offered
11.4.5 AbbVie Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Details
11.5.2 Company Business Overview
11.5.3 Novo Nordisk Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Novo Nordisk Specialty Pharmaceutical Products Offered
11.5.5 Novo Nordisk Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Company Business Overview
11.6.3 Johnson & Johnson Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Johnson & Johnson Specialty Pharmaceutical Products Offered
11.6.5 Johnson & Johnson Recent Development
11.7 Sanofi-Aventis
11.7.1 Sanofi-Aventis Company Details
11.7.2 Company Business Overview
11.7.3 Sanofi-Aventis Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Sanofi-Aventis Specialty Pharmaceutical Products Offered
11.7.5 Sanofi-Aventis Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Company Business Overview
11.8.3 Merck Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Merck Specialty Pharmaceutical Products Offered
11.8.5 Merck Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Company Business Overview
11.9.3 Eli Lilly Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Eli Lilly Specialty Pharmaceutical Products Offered
11.9.5 Eli Lilly Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Company Business Overview
11.10.3 Novartis Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Novartis Specialty Pharmaceutical Products Offered
11.10.5 Novartis Recent Development
11.11 3sbio
11.12 Changchun High Tech
11.13 CP Guojian Pharmacy
11.14 Biotech Pharma
11.15 Gelgen Biopharma
11.16 Innovent
12 Future Forecast
12.1 Specialty Pharmaceutical Market Forecast by Regions
12.1.1 Global Specialty Pharmaceutical Sales Forecast by Regions 2021-2027
12.1.2 Global Specialty Pharmaceutical Revenue Forecast by Regions 2021-2027
12.2 Specialty Pharmaceutical Market Forecast by Product
12.2.1 Global Specialty Pharmaceutical Sales Forecast by Product 2021-2027
12.2.2 Global Specialty Pharmaceutical Revenue Forecast by Product 2021-2027
12.3 Specialty Pharmaceutical Market Forecast by End User
12.4 North America Specialty Pharmaceutical Forecast
12.5 Europe Specialty Pharmaceutical Forecast
12.6 Asia Pacific Specialty Pharmaceutical Forecast
12.7 Central & South America Specialty Pharmaceutical Forecast
12.8 Middle East and Africa Specialty Pharmaceutical Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Specialty Pharmaceutical Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
